| Jeff Ruggles, | |
|
1075 Camino Del Rio S, San Diego, CA 92108-3538 | |
| (619) 881-5094 | |
| (866) 886-7824 |
| Full Name | Jeff Ruggles |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1075 Camino Del Rio S, San Diego, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023547064 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 54378 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeff Ruggles, 10058 Rock Meadow Rd, Lakeside, CA 92040-2784 Ph: () - | Jeff Ruggles, 1075 Camino Del Rio S, San Diego, CA 92108-3538 Ph: (619) 881-5094 |
News Archive
TIME reports that states "could have a surprising degree of autonomy in determining how they implement" federal health reforms. "Though most everyone recognizes that the federal government can't impose a rigid approach, some critics say that the crucial version of legislation expected to pass Senator Max Baucus' Finance Committee in the next week ... may go too far in the other direction."
Research carried out in two distinct communities in Colombia illustrates how coevolution between humans and bacteria can affect a person's risk of disease. Working with colleagues in Columbia and the U.S., Scott Williams, PhD, a professor of genetics at the Geisel School of Medicine at Dartmouth, and his graduate student Nuri Kodaman discovered that the risk of developing gastric cancer depends heavily on both the ancestry of the person and the ancestry of Helicobacter pylori with which that person is infected.
Diamyd Medical reports that results from its European Phase III study with the antigen-based therapy Diamyd did not meet the primary efficacy endpoint of preserving beta cell function at 15 months, as measured by meal stimulated C-peptide, in newly diagnosed type 1 diabetes patients.
BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 4 days ago
Kristen A Cote, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6405 El Cajon Blvd, San Diego, CA 92115 Phone: 619-286-8397 | |
Kathy Truong, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4029 43rd Street, Suite 700, San Diego, CA 92105 Phone: 619-521-9753 Fax: 619-521-4837 | |
Camthi Sager, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6405 El Cajon Blvd, San Diego, CA 92115 Phone: 619-286-3470 Fax: 619-286-2063 | |
Richard Fung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 626-278-2749 | |
Dr. Jennifer Ingrid Purificacion, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 University Ave, San Diego, CA 92103 Phone: 619-295-6688 | |
Ms. Misty Laree Cole, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8766 Navajo Rd, San Diego, CA 92119 Phone: 619-667-8764 | |
Tammy Minh Tran, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16773 Bernardo Center Dr, San Diego, CA 92128 Phone: 858-451-2630 |